Scientific interest in why some people live well past a century has grown steadily as populations age and healthcare advances extend average life expectancy. Among the many questions researchers explore is whether biological traits present from birth, including blood type, may influence the odds of exceptional longevity. Several studies have suggested that people with certain blood types, most notably type O, appear more frequently among centenarians than others. While blood type alone does not determine lifespan, researchers increasingly view it as one piece of a much larger biological puzzle. Genetics, lifestyle, environment, and long-term metabolic stability all interact over decades, shaping how the body responds to stress, disease, and aging itself. Rather than pointing to a single secret of long life, modern research paints longevity as the result of sustained balance and resilience across multiple physiological systems.

One of the most influential contributions to this understanding comes from a long-running Swedish study that followed more than 44,000 individuals over a span of 35 years. Researchers examined routine blood test results collected throughout adulthood and compared those who eventually reached 100 years of age with those who did not. Their findings challenged many assumptions about aging and health. Instead of extreme “perfect” lab values, centenarians consistently showed moderate, stable levels across a range of key biomarkers for decades before reaching advanced age. This pattern suggests that longevity is less about aggressively optimizing individual measurements and more about maintaining overall biochemical harmony. The body appears to benefit from avoiding chronic extremes, whether too high or too low, and instead sustaining a steady internal environment capable of adapting to gradual change.

Among the most notable findings were consistently lower levels of glucose, creatinine, and uric acid in those who lived to 100. Lower glucose levels are associated with reduced risk of diabetes and vascular damage, while balanced creatinine and uric acid suggest healthier kidney function and reduced systemic inflammation. At the same time, liver enzymes such as ALT and AST tended to remain within stable, moderate ranges, indicating long-term liver health. These markers reflect the body’s ability to manage waste, regulate energy, and detoxify efficiently over many decades. Importantly, these favorable patterns were often present as early as middle age, reinforcing the idea that longevity is built gradually rather than achieved through late-life interventions alone.

Perhaps most surprising to researchers was what centenarians did not show: extremely low cholesterol or iron levels. Contrary to widely held beliefs that lower is always better, individuals who lived the longest often maintained moderately higher total cholesterol and iron levels well into later life. This challenges simplistic interpretations of cardiovascular risk and highlights the complexity of aging physiology. In advanced age, adequate cholesterol supports hormone production and cell membrane integrity, while sufficient iron helps prevent frailty and anemia. These findings suggest that overly aggressive reduction of certain biomarkers, particularly in older adults, may unintentionally undermine resilience. Longevity appears to favor balance over deprivation, with the body benefiting from adequate nutritional and metabolic reserves as it ages.

The role of blood type fits into this broader framework as a potential modifier rather than a determinant of lifespan. Blood type O, for example, has been associated in multiple studies with lower risks of cardiovascular disease and blood clotting disorders, conditions that significantly impact survival in later decades. People with type O blood may also show more favorable inflammatory and immune responses, which could contribute to reduced cumulative damage over time. However, researchers emphasize that these associations are probabilistic, not guarantees. Many people with other blood types also reach exceptional ages, while many with type O do not. Blood type may tilt the odds slightly, but it operates alongside lifestyle factors such as diet, physical activity, stress management, and access to healthcare.

Taken together, these findings reshape how longevity is understood and pursued. Rather than focusing narrowly on individual targets or genetic traits, the evidence points toward the importance of long-term metabolic stability, moderation, and adaptability. Maintaining balanced blood sugar, kidney function, liver health, and nutritional status over decades appears far more influential than chasing idealized lab values at any single point in time. Blood type may provide a small, inherent advantage for some, but it is sustained physiological balance that ultimately supports a long and healthy life. As science continues to unravel the biology of aging, the emerging lesson is clear: reaching 100 is less about extremes or shortcuts and more about cultivating steady, resilient health across the entire lifespan.